Lipocine (LPCN) EBIT Margin (2018 - 2025)
Lipocine's EBIT Margin came in at -2933.51% for Q3 2025, down 2547.49 percentage points from the prior quarter.
Powered by 
Analysis
Lipocine (LPCN) EBIT Margin (2018 - 2025) Analysis & Trends
Over the trailing twelve months to Sep 30, 2025, Lipocine reported EBIT Margin of -145.98%, down 75.30 percentage points year-over-year; for FY2024, it was -10.31%, up 618.66 percentage points from FY2023.
- EBIT Margin carries a five-year change of +7808.52 percentage points (FY2019 to FY2024).
- Going back by year, EBIT Margin was -628.98% in FY2023 (+1794.90 pp), -2423.88% in FY2022 (-2443.36 pp) and 19.49% in FY2021.
- The Q3 2025 figure represents the lowest quarterly EBIT Margin since Q2 2024.
- Business Quant data shows LPCN's EBIT Margin at -386.03% (Q2 2025), -2226.82% (Q1 2025) and 44.27% (Q4 2024) in the three quarters before Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 32.97% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 20.57% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.95% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -133.21% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 28.37% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 37.40% |
| 10 | Lipocine | 11.33 Mn | -56.39 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -2,933.51% |
| Jun 30, 2025 | -386.03% |
| Mar 31, 2025 | -2,226.82% |
| Dec 31, 2024 | 44.27% |
| Jun 30, 2024 | -3,676.18% |
| Mar 31, 2024 | 42.31% |
| Sep 30, 2023 | -225.60% |
| Mar 31, 2023 | -7,889.86% |
| Jun 30, 2022 | -705.51% |
| Dec 31, 2021 | 79.47% |
| Sep 30, 2021 | -6,424.86% |
| Sep 30, 2019 | -1,803.56% |
| Mar 31, 2018 | -616.07% |
API Access
Lipocine EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=LPCN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "LPCN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=LPCN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();